Heterogeneity and optimal study design between cell lines in induced pluripotent stem cell-based cardiac disease...

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Toxicology

Background:

• Human-induced pluripotent stem cell (hiPSC) technologies provide in vitro models of human cardiomyocytes (CMs) for disease, therapy, and toxicology studies.
• Reproducibility and data integration are challenged by variability in hiPSC lines, clones, and batches, stemming from donor differences, genetic stability, and experimental factors.

Purpose of the Study:

• To review hiPSC-CM usage across multiple lines.
• To evaluate experimental variation in hiPSC models.
• To inform in vitro power calculations and guide future biomedical applications.

Main Methods:

• Meta-analysis of 21 published case-control studies using hiPSC lines.
• Evaluation of functional parameter heterogeneity.
• Assessment of standard deviation (SD) in specific CM readouts.

Main Results:

• High heterogeneity exists between hiPSC-CM functional parameters, even with multiple lines used.
• In some CM readouts, the SD exceeds 40%, indicating cell line variation surpasses biological or drug effects.
• The variability underscores challenges in achieving robust and reproducible hiPSC-based research.

Conclusions:

• A need exists for careful selection of hiPSC lines, appropriate controls, and stable readouts.
• Understanding and mitigating experimental variability is essential for enhancing the power of hiPSC models.
• These insights are critical for advancing the utility of hiPSC-CMs in biomedical research and drug development.